Skip to main content

Advertisement

Log in

Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Pessary treatment for pelvic organ prolapse (POP) is effective and safe, but long-term continuation is low. Pain and vaginal discharge may play a role. This study was aimed at evaluating vaginal discharge and pain during pessary cleaning in an outpatient setting and in continuous pessary use.

Methods

Women with POP who attended the outpatient clinic for pessary cleaning between January and October 2021 were included. Primary outcome was pain during removal and reinsertion of the pessary, measured by an 11-point numeric rating scale (NRS). Secondary outcome was vaginal discharge, measured by the NRS and Patient Global Impression of Change scale (PGI-C). Multiple linear regression analysis was used to identify associated variables for pain and discharge.

Results

A total of 150 women were included. Mean NRS during pessary removal was 4.3 (± 2.7), with 25% of women scoring a 7 or higher. Mean NRS during reinsertion was 1.8 (± 2.0). A smaller genital hiatus and presence of vaginal atrophy or vulvar skin disease were associated with pain during pessary removal. Mean NRS for vaginal discharge was 2.5 (± 2.3). Twenty-five percent of women reported that their vaginal discharge was “(very) much worse” than before they used a pessary. Presence of vaginal erosions was associated with vaginal discharge in this study population.

Conclusions

Removing a pessary in an outpatient setting is a painful procedure for many women who use a pessary continuously. Moreover, 25% of these women experience an increase in vaginal discharge while using a pessary. Future research should focus on reducing these disadvantages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author, Kruyt LM, upon request.

References

  1. Åkervall S, Al-Mukhtar Othman J, Molin M, Gyhagen M. Symptomatic pelvic organ prolapse in middle-aged women: a national matched cohort study on the influence of childbirth. Am J Obstet Gynecol. 2020;222(4):356.e1–14.

    Article  PubMed  Google Scholar 

  2. Islam RM, Oldroyd J, Rana J, Romero L, Karim MN. Prevalence of symptomatic pelvic floor disorders in community-dwelling women in low and middle-income countries: a systematic review and meta-analysis. Int Urogynecol J. 2019;30:2001–11.

    Article  PubMed  Google Scholar 

  3. Slieker-ten Hove MCP, Pool-Goudzwaard AL, Eijkemans MJC, Steegers-Theunissen RPM, Burger CW, Vierhout ME. Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol. 2009;200(2):184.e1–7.

    Article  PubMed  Google Scholar 

  4. Sansone S, Sze C, Eidelberg A, et al. Role of pessaries in the treatment of pelvic organ prolapse: a systematic review and meta-analysis. Obstet Gynecol. 2022;140(4):613–22.

    Article  PubMed  Google Scholar 

  5. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cheung RYK, Lee JHS, Lee LL, Chung TKH, Chan SSC. Vaginal pessary in women with symptomatic pelvic organ prolapse. Obstet Gynecol. 2016;128(1):73–80.

    Article  PubMed  Google Scholar 

  7. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(2):345–50.

    Article  PubMed  Google Scholar 

  8. Deng M, Ding J, Ai F, Zhu L. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use. Menopause. 2017;24(8):954–8.

    Article  PubMed  Google Scholar 

  9. Ding J, Chen C, Song XC, Zhang L, Deng M, Zhu L. Changes in prolapse and urinary symptoms after successful fitting of a ring pessary with support in women with advanced pelvic organ prolapse: a prospective study. Female Urol. 2016;87:70–5.

    Article  PubMed  Google Scholar 

  10. Coelho SCA, Giraldo PC, Benedito de Castro E, Brito LGO, Juliato CRT. Risk factors for dislodgment of vaginal pessaries in women with pelvic organ prolapse: a cohort study. Female Pelvic Med Reconstr Surg. 2021;27(1):247–251.

    Article  Google Scholar 

  11. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025–9.

    Article  PubMed  Google Scholar 

  12. Deng M, Ding J, Ai F, Zhu L. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse. Menopause. 2017;24(11):1277–81.

    Article  PubMed  Google Scholar 

  13. Bai SW, Yoon BS, Kwon JY, Shin JS, Kim SK, Park KH. Survey of the characteristics and satisfaction degree of the patients using a pessary. Int Urogynecol J. 2005;16(3):182–6.

    Article  Google Scholar 

  14. Thys S, Hakvoort R, Milani A, Roovers JP, Vollebregt A. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study. Int Urogynecol J. 2021;32(8):2159–67.

    Article  PubMed  Google Scholar 

  15. Broens-Oostveen M, Mom R, Lagro-Janssen A. Genital prolapse; treatment and course in four general practices. Ned Tijdschr Geneeskd. 2004;148(29):1444–8.

    CAS  PubMed  Google Scholar 

  16. Sarma S, Ying T, Moore KH. Long-term vaginal ring pessary use: discontinuation rates and adverse events. BJOG. 2009;116(13):1715–21.

    Article  CAS  PubMed  Google Scholar 

  17. de Albuquerque Coelho SC, de Castro EB, Juliato CRT. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016;27(12):1797–803.

    Article  PubMed  Google Scholar 

  18. de Albuquerque Coelho SC, Brito LGO, de Araujo CC, Juliato CRT. Factors associated with unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: systematic review and metanalysis. Neurourol Urodyn. 2020;39(7):1912–21.

    Article  PubMed  Google Scholar 

  19. Abdulaziz M, Stothers L, Lazare D, Macnab A. An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse. J Can Urol Assoc. 2015;9(6):E400–6.

    Article  Google Scholar 

  20. Kakkar A, Reuveni-Salzman A, Bentaleb J, Belzile E, Merovitz L, Larouche M. Adverse events associated with pessary use over one year among women attending a pessary care clinic. Int Urogynecol J. 2023;34(8):1765–70. https://doi.org/10.1007/s00192-023-05462-z.

    Article  PubMed  Google Scholar 

  21. Collins S, Beigi R, Mellen C, O’Sullivan D, Tulikangas P. The effect of pessaries on the vaginal microenvironment. Am J Obstet Gynecol. 2015;212(1):60.1–6.

    Article  Google Scholar 

  22. De Albuquerque Coelho SC, Giraldo PC, Florentino JO, de Castro EB, Brito LGO, Juliato CRT. Can the pessary use modify the vaginal microbiological flora? A cross-sectional study. Rev Bras Ginecol Obstet. 2017;39(4):169–74.

    Article  Google Scholar 

  23. Alnaif B, Drutz HP. Bacterial vaginosis increases in pessary users. Int Urogynecol J. 2000;11(4):219–23.

    Article  CAS  Google Scholar 

  24. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10(4):390–2.

    Article  PubMed  Google Scholar 

  25. Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med 2018;36:707–14.

    Article  PubMed  Google Scholar 

  26. Bakker R, Peng K, Chelmow D. Speculum lubrication and patient comfort: a meta-analysis of randomized controlled trials. J Low Genit Tract Dis. 2017;21(1):67–72.

    Article  PubMed  Google Scholar 

  27. Law HY, Ng DYT, Chung CD. Use of music in reducing pain during outpatient hysteroscopy: prospective randomized trial. J Obstet Gynaecol Res. 2021;47(3):904–12.

    Article  PubMed  Google Scholar 

  28. Deo N, Khan KS, Mak J, et al. Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial. BJOG. 2021;128(1):87–95.

    Article  CAS  PubMed  Google Scholar 

  29. Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M. Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer. 2017;16(2):205–10.

    Article  PubMed  Google Scholar 

  30. Abbas AM, Samy A, El-NaserAbd El-Gaber Ali A, et al. Medications for pain relief in outpatient endometrial sampling or biopsy: a systematic review and network meta-analysis. Fertil Steril. 2019;112(1):140–8.e12.

    Article  PubMed  Google Scholar 

  31. Chien CW, Lo TS, Tseng LH, Lin YH, Hsieh WC, Lee SJ. Long-term outcomes of self-management Gellhorn pessary for symptomatic pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2020;26(11):e47–53.

    Article  PubMed  Google Scholar 

  32. Ziv E, Erlich T. Novel, disposable, self-inserted, vaginal device for the non-surgical management of pelvic organ prolapse: efficacy, safety, and quality of life. BMC Womens Health. 2022;22(1):459. https://doi.org/10.1186/s12905-022-02057-6.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Miceli A, Fernández-Sánchez M, Dueñas-Díez JL. How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study. Int Urogynecol J. 2021;32(6):1471–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Propst K, Mellen C, O’Sullivan DM, Tulikangas PK. Timing of office-based pessary care: a randomized controlled trial. Obstet Gynecol. 2020;135(1):100–5.

    Article  PubMed  Google Scholar 

  35. Manchana T. Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet. 2011;284(2):391–5.

    Article  PubMed  Google Scholar 

  36. Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse. Int Urogynecol J. 2018;29(8):1123–8.

    Article  PubMed  Google Scholar 

  37. Devi AS, Anuradha J. The effect of pessaries on vaginal micro environment. IAIM. 2017;4(7):18–22.

    Google Scholar 

  38. Yoshimura K, Morotomi N, Fukuda K, Hachisuga T, Taniguchi H. Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora. Int Urogynecol J. 2016;27(2):219–27.

    Article  PubMed  Google Scholar 

  39. Ramaseshan A, Mellen C, O’Sullivan D, Nold C, Tulikangas P. Host inflammatory response in women with vaginal epithelial abnormalities after pessary use. Int Urogynecol J. 2022;33(8):2151–7.

    Article  PubMed  Google Scholar 

  40. Meriwether KV, Rogers RG, Craig E, Peterson SD, Gutman RE, Iglesia CB. The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial. Am J Obstet Gynecol. 2015;213(5):729.e1–e9.

    Article  CAS  PubMed  Google Scholar 

  41. Ai F, Wang Y, Wang J, Zhou L, Wang S. Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis. Climacterium. 2022;25(6):533–42.

    Article  CAS  Google Scholar 

  42. Taithongchai A, Johnson EE, Ismail SI, Barron-Millar E, Kernohan A, Thakar R. Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev. 2023;7(7):CD014592. https://doi.org/10.1002/14651858.CD014592.pub2

    Article  PubMed  Google Scholar 

  43. Moore KH, Lammers K, Allen W, Parkin K, te West N. Does monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit. Eur J Obstet Gynecol Reprod Biol X. 2022;16:100164.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Yoshimura K, Morotomi N, Fukuda K, Kubo T, Taniguchi H. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse. J Obstet Gynaecol Res. 2020;46(6):931–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Lara M. Kruyt: protocol development, data collection, data analysis, manuscript writing; J. Marinus van der Ploeg: protocol development, data collection, data analysis, manuscript writing; Karin Lammers: data collection, manuscript editing; Britt A. van Etten-Debruijn: data collection, manuscript editing; Anuschka S. Niemeijer: statistical analysis, manuscript editing; Robert A. Hakvoort: protocol development, data collection, data analysis, manuscript writing.

Corresponding author

Correspondence to Lara M. Kruyt.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kruyt, L.M., van der Ploeg, J.M., Lammers, K. et al. Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting. Int Urogynecol J 35, 333–339 (2024). https://doi.org/10.1007/s00192-023-05648-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-023-05648-5

Keywords

Navigation